Hemoglobin catalyzes CoA degradation and thiol addition to flavonoids by Nagakubo Toshiki et al.
Hemoglobin catalyzes CoA degradation and thiol
addition to flavonoids
著者 Nagakubo Toshiki, Kumano Takuto, Hashimoto
Yoshiteru, Kobayashi Michihiko
journal or
publication title
Scientific reports 
volume 8
page range 1282
year 2018-01
権利 (C) The Author(s) 2018
 This article is licensed under a Creative
Commons Attribution 4.0 International 
License, which permits use, sharing,
adaptation, distribution and reproduction in
any medium or  format, as long as you give
appropriate credit to the original author(s)
and the source, provide a link to the Cre-
ative Commons license, and indicate if changes
were made. The images or other third party
material in this  article are included in the
article’s Creative Commons license, unless
indicated otherwise in a credit line to the 
material. If material is not included in the
article’s Creative Commons license and your
intended use is not per- mitted by statutory
regulation or exceeds the permitted use, you
will need to obtain permission directly from
the  copyright holder. To view a copy of this
...
URL http://hdl.handle.net/2241/00151037
doi: 10.1038/s41598-018-19585-7
Creative Commons : 表示
http://creativecommons.org/licenses/by/3.0/deed.ja
1Scientific RepoRTs |  (2018) 8:1282  | DOI:10.1038/s41598-018-19585-7
www.nature.com/scientificreports
Hemoglobin catalyzes CoA 
degradation and thiol addition to 
flavonoids
Toshiki Nagakubo, Takuto Kumano, Yoshiteru Hashimoto & Michihiko Kobayashi
In the presence of CoA, cell-free extracts prepared from porcine liver was found to convert 
7,8-dihydroxyflavone (DHF) to a pantetheine conjugate, which was a novel flavonoid. We purified 
a 7,8-DHF-converting enzyme from the extracts, and identified it as hemoglobin (Hb). The purified 
Hb showed the following two activities: (i) degradation of CoA into pantetheine through hydrolytic 
cleavage to yield pantetheine and 3′-phospho-adenosine-5′-diphosphate (ADP) independently of 
heme, and (ii) addition of a thiol (e.g., pantetheine, glutathione and cysteine) to 7,8-DHF through 
C-S bond formation. Human Hb also exhibited the above flavonoid-converting activity. In addition, 
heme-containing enzymes such as peroxidase and catalase added each of pantetheine, glutathione 
and cysteine to the flavonoid, although no pantetheine conjugates were synthesized when CoA was 
used as a substrate. These findings indicated that the thiol-conjugating activity is widely observed in 
heme-containing proteins. On the other hand, only Hb catalyzed the hydrolysis of CoA, followed by the 
thiol conjugation to synthesize the pantetheine conjugate. To the best of our knowledge, this is the first 
report showing that Hb has the catalytic ability to convert naturally occurring bioactive compounds, 
such as dietary flavonoids, to the corresponding conjugates in the presence of thiol donors or CoA.
For many years, natural products have been recognized as a rich source of compounds for drug discovery. Various 
kinds of antibiotics and bioactive compounds were discovered from natural resources1. In many countries, on 
the other hand, chronic diseases such as cancer, heart disease, and stroke remain considerable public concerns. 
Traditionally, a plant-based diet, which usually contains various flavonoids, is thought to reduce the risk of these 
diseases and to promote health. Thousands of flavonoids have been isolated from plants. Plants synthesize flavo-
noids to protect themselves from various environmental stressors such as harmful ultraviolet (UV) radiation and 
oxidative species2.
A number of epidemiological studies suggested that flavonoids in vegetables and fruits protect humans 
against chronic diseases3. Inhibitory effects on the activities of mammalian enzyme systems and the free 
radical-scavenging activities of flavonoids contribute to the protection against such diseases4. The ingested fla-
vonoids in humans are metabolized through two pathways, as follows. (i) In the small intestine and liver, fla-
vonoids are glucuronidated, sulfonated and O-methylated by UDP-glucuronosyltranferase, sulfotransferase 
and catechol-O-methyltransferase, respectively5. (ii) Intestinal bacteria degrade flavonoids into a variety of 
hydroxylated phenyl carboxylic acids5. Flavonoids absorbed by the small intestine are exclusively converted into 
conjugates in the liver, and the resultant conjugates enter the circulatory system6. These conjugates are mostly 
deconjugated in tissues. The resulting flavonoid aglycones are considered to have biological functions in the 
cell7. However, it is also proposed that the conjugated metabolites themselves show antioxidative activities and 
inhibitory effects on the activities of some mammalian enzymes8. For example, quercetin and its glucuronidated 
metabolite inhibited myeloperoxidase, which catalyzes low-density lipoprotein oxidation9. Also, an O-methylated 
flavonoid inhibited the activity of NADPH oxidase, which generates reactive oxygen species (ROS) in the inflam-
mation process10. Moreover, glucuronidated and sulfated flavonoids showed protective activity against endothe-
lial dysfunction in vivo11. These unique activities of metabolized flavonoids are a part of the bioactivity of ingested 
flavonoids. Therefore, identification of a novel metabolite of a flavonoid and a flavonoid-converting enzyme is 
essential for understanding of the functions of dietary flavonoids.
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In our laboratory, recently, we have studied the metabolism of biologically active natural compounds, such 
as curcumin12, sesamin13, and piperonal14. Very recently, particularly, we proposed a new biocatalyst concept; 
actinorhodin, a natural low-molecular mass organic compound, acts as a biocatalyst under physiological condi-
tions15. This finding opens the door to a new field of organocatalysts in living organisms. In the present article, we 
show that heme-containing catalysts including hemoglobin (Hb), peroxidase and catalase add each of thiols (e.g., 
pantetheine, glutathione and cysteine) to flavonoids. Moreover, we report that Hb has the ability to cleave CoA to 
yield pantetheine and 3′-phospho-ADP (Fig. 1). We propose a new function of Hb.
Results
Detection of a novel metabolite of 7,8-dihydroxyflavone. In order to detect and identify a novel 
metabolite of a flavonoid, we incubated cell-free extracts prepared from the liver of a pig with 7,8-dihydrox-
yflavone (DHF) for 10 h at 37 °C. After incubation of the reaction mixture, however, no reaction product was 
observed on LC/MS analyses. Next, we added each of AMP, ADP, ATP, NADH, NADPH, NAD+, NADP+, FAD, 
FMN, inositol, thiamine·HCl, pantothenic acid, vitamin B6, and CoA (Fig. 2) to the above reaction mixture at a 
final concentration of 1 mM. After incubation for 7 h at 37 °C, the products that could be derived from 7,8-DHF 
were formed when CoA was added to the reaction mixture (Fig. S1). One of the reaction products gave a [M-H]− 
ion at m/z 529.1631, which is in good agreement with the molecular formula [C26H29N2O8S]−. This molecular 
formula corresponded with that of the pantetheine conjugate of 7,8-DHF. Unexpectedly, these results indicate 
that CoA was used as a substrate but not as a cofactor, being degraded into pantetheine and adducted to 7,8-DHF 
by a 7,8-DHF-converting enzyme.
Purification and identification of the 7,8-DHF-converting enzyme. Through the purification steps 
described under “Methods”, the 7,8-DHF-converting enzyme was purified over seven-fold, with a yield of 0.230%, 
Figure 1. The reaction scheme for the formation of pantetheine-conjugated 7,8-DHF by Hb. The compounds in 
this figure are as follows; CoA (1), pantetheine (2), 3′-phospho-ADP (3), 7,8-DHF (4), pantetheine-conjugated 
7,8-DHF (5).
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from the liver of a pig (Table S1). The purified enzyme gave two bands on SDS-PAGE, which corresponded to 
molecular masses of 15 and 16 kDa (Fig. S2).
In order to identify the 7,8-DHF-converting enzyme, partial N-terminal amino acid sequencing was carried 
out. The 20 amino acid sequences of the two subunits were as follows: VLSAADKANVKAAWGIVGGQ (15 kDa 
small subunit) and VHLSAEEKEAVLGLWGKVNV (16 kDa large subunit). A search with the BLAST program 
revealed that these N-terminal amino acid sequences exhibited high similarity (95% and 100%, respectively) with 
those of hemoglobin (Hb) subunit alpha and beta of Sus scrofa (pig), respectively.
We then investigated whether the purified Hb is identical to blood Hb (from the same pig) or not. Blood Hb 
was purified from red blood cells of the pig with a HiPrep DEAE FF 16/10 column after hemolysis (Table S2). The 
purified blood Hb gave two bands on SDS-PAGE, and the apparent molecular mass of the blood Hb was the same 
as that of that from liver (Fig. S3). The molecular masses of the subunits of both proteins were also determined by 
MALDI-TOF/MS to be as follows: alpha subunit, 15065.991 (from liver) and 15065.619 (from blood); and beta 
subunit, 16064.434 (from liver) and 16064.710 (from blood). These molecular masses show that both subunits of 
Hb from liver are identical to the corresponding subunits of Hb from red blood cells. Furthermore, the molecular 
masses of the heme extracted from Hb of blood and liver were determined by LC-ESI-MS as described under 
“Methods”, both hemes exhibiting a m/z value of 616.2 in the positive ion mode. This m/z value corresponded 
with that of protoporphyrin IX and iron16. Therefore, the purified enzyme from porcine liver was identified as Hb, 
which is a tetrameric protein comprising two alpha subunits and two beta subunits (α2β2).
By using the purified Hb from liver, the product that shows the m/z value of 529.1631 was clearly formed 
(Fig. S4). Using CoA as a substrate, we next compared the activities of Hb from porcine blood and human blood 
with that of Hb from porcine liver (Table S3). Both of them exerted the activity, but it was lower than that of Hb 
from porcine liver.
Pantetheine as a substrate for Hb. The results of mass spectrometry analysis described under “Detection 
of a novel metabolite of 7,8-DHF” indicated the reaction product was the pantetheine conjugate of 7,8-DHF. We 
thus tested pantetheine as a substrate for the Hb reaction. Pantetheine was prepared from pantethine (dimeric 
form of pantetheine) with a 4-fold higher concentration of DTT, and then purified by HPLC. The reaction was 
carried out in the standard assay mixture using purified pantetheine as a thiol substrate. In this reaction, the 
product exhibited the same m/z value and retention time ([M-H]− ion at m/z 529.2 and 8.4 min) as the product 
observed when CoA was used as a substrate. On the other hand, the specific activity of Hb increased to 1.01 μmol/
min/mg from 0.403 × 10−3 μmol/min/mg by using pantetheine as a substrate instead of CoA (Table 1).
Structure determination of the pantetheine conjugate. The pantetheine conjugate of 7,8-DHF 
was prepared and purified as described under “Methods”. We determined its structure by NMR analysis (Fig. 3, 
Table S4 and Figs S5–9). Heteronuclear multiple bond coherence (HMBC) analysis revealed the correlation 
between H-2” of the pantetheine moiety and C-6 of the flavonoid moiety. This observation demonstrates that the 
thiol group of pantetheine was adducted to C-6 of 7,8-DHF.
Degradation of CoA by Hb and Co-bound Hb. We then investigated the mechanism of degradation of 
CoA by Hb. When CoA was incubated with Hb, CoA was consumed and two products were observed (Fig. 4). 
The m/z values of the products were 506 [M-H]− and 277 [M-H]−, indicating that Hb cleaved the CoA at the Z 
Figure 2. The structure of CoA. Arrows X, Y, and Z indicate the cleavage sites in CoA for CoA phosphatase, 
dephospho-CoA pyrophosphatase and Hb, respectively.
Thiol donor Specific activity (μmol/min/mg)
Glutathione 1.35 ± 0.12
Cysteine 1.29 ± 0.09
Pantetheine 1.01 ± 0.11
CoA 0.403 ± 0.033 (×10−3)
Table 1. 7,8-DHF-converting activity of Hb from blood with various thiol donors. Hb from blood was added 
to the standard assay mixture. The final concentration of glutathione, cysteine, pantetheine, and CoA was 
2 mM. Activities were calculated from the decrease in the amount of 7,8-DHF after reactions when glutathione, 
cysteine, and pantetheine were used as substrates.
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arrow in Fig. 2 to yield 3′-phospho-adenosine-5′-diphosphate (ADP) and pantetheine. In this reaction, the activ-
ity of CoA degradation by Hb was measured to be 0.657 ± 0.105 × 10−3 μmol/min/mg.
By LC/MS, we investigated this reaction by using CO treated Hb. The specific activity of CO-bound Hb was 
0.311 ± 0.016 × 10−3 μmol/min/mg.
Effect of the redox state of heme on the activity of Hb. We investigated the effects of the redox state 
and ligands on the activity of Hb. At first, we examined the effects of ligands (i.e., KCN and CO) and redox rea-
gents (i.e., dithionite (Na2S2O4) and potassium ferricyanide (K3[Fe(CN)6]), under aerobic and anaerobic condi-
tions. The spectra of the purified Hb drastically changed on the addition of various compounds (Fig. S10). These 
spectral shifts coincided with those reported previously17. The addition of CO or dithionite decreased the activity 
of Hb under anaerobic conditions. Also, the addition of potassium ferricyanide and KCN reduced the enzymatic 
activity by 60–80% under aerobic conditions (Table S5). These results showed that dioxygenated (Fe2+-O2) or 
oxidized (Fe3+) heme was required to convert 7,8-DHF to the corresponding conjugate.
Effects of temperature and pH on the activity and stability of Hb. The effects of pH and temper-
ature on the activity of Hb were examined (Fig. S11). The optimum pH and temperature were pH 8.5–9.0 and 
45 °C, respectively. Hb was stable between pH 5.0 and pH 11.0, and under 50 °C.
The stability of Hb was examined at various pH values. After Hb had been incubated at 25 °C for 30 min in 
100 mM buffers, citrate/sodium citrate buffer (pH 3.0–6.5), Hepes/NaOH buffer (pH 6.5–8.0), Tris/HCl buffer 
(pH 8.0–9.0), NH4Cl/NH4OH buffer (pH 9.0–10.0), and NaHCO3/NaOH buffer (pH 10.0–11.0), an aliquot of 
each enzyme solution was taken and assayed under the standard conditions. The activity of Hb was maintained 
even after high pH (pH 11.0) treatment. This is in agreement with previously reported results showing that the 
extent of denaturation of a hemolysate was relatively low after high pH (pH 12.5) treatment18.
The stability of Hb was examined at various temperatures. After Hb had been preincubated for 30 min in 100 mM 
Hepes-NaOH (pH 7.4), an aliquot of each solution was taken, and then the activity of Hb was assayed under the 
standard conditions. The activity of Hb was suddenly lost above 60 °C, which is in agreement with previously 
reported results showing that a rapid increase in the rate of denaturation of Hb was observed above 60 °C19.
Kinetic properties of Hb. Using CoA and different concentrations of 7,8-DHF as substrates, a typical 
hyperbolic curve of pantetheine-conjugated product formation over substrate concentration was obtained, indi-
cating that the reaction followed Michaelis-Menten-type kinetics (Fig. S12). The Km, Vmax, and kcat values were 
0.404 ± 0.081 mM, 0.466 × 10−3 ± 0.161 × 10−3 μmol/min/mg, and 1.24 × 10−3 s−1, respectively.
Substrate specificity. The substrate specificity of Hb toward various flavonoids was assayed by LC-ESI-MS 
in the standard assay mixture containing 2 mM CoA, 0.2–1 mM each flavonoid, and 1 mg/ml Hb. Among the 
tested flavonoids, quercetin, (+)-catechin, and naringenin were converted to the corresponding products, which 
Figure 3. Determined structure of the pantetheine conjugate of 7,8-DHF.
Figure 4. Degradation of CoA by Hb or CO-bound Hb. The standard reaction mixture containing 2.5 mg/mL 
Hb was incubated under air (gray) or CO (black). As a control, substrates were incubated under air (white). 
Amount of CoA was measured by LC/MS.
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exhibited the m/z values of pantetheine conjugates (Fig. 5). However, flavone, 7-hydroxyflavone (8-dehydroxylated 
derivative of 7,8-DHF), apigenin (3-dehydroxylated derivative of quercetin), (−)-epicatechin (diastereomer of 
(+)-catechin), 4′,5-dihydroxyflavone (3,7-dehydroxylated derivative of quercetin), and 4′-hydroxyflavone were 
inert as substrates for Hb. This indicates that the number and position of the hydroxyl group of a flavonoid is 
unrelated to the activity of Hb. On the other hand, Hb did not convert isoflavones (daidzein and genistein) into 
pantetheine conjugates. When pantetheine, glutathione, and cysteine were used as substrates instead of CoA, Hb 
was found to act on a much broader range of flavonoids including isoflavones (Table S6).
Flavonoid-converting activity of heme-containing enzymes. We investigated the flavonoid-converting 
activity of the heme-containing enzymes, peroxidase and catalase. We incubated each of these enzymes with a 
thiol donor and 7,8-DHF and then analyzed the resultant reaction mixture by LC/MS. Both heme-containing 
enzymes showed flavonoid-converting activity when glutathione, cysteine or pantetheine were used as a thiol 
donor. While the conjugation-activity of Hb was higher than those of peroxidase and catalase when glutathione 
and cysteine were used as a substrate, that of catalase was higher than those of Hb and peroxidase when panteth-
eine was used as a substrate (Table 2).
The effects of ROS scavengers on the activity of Hb. We detected non-enzymatic and time-dependent 
production of H2O2 in the presence of 7,8-DHF (Fig. S13), and the addition of H2O2 to the reaction mixture 
increased the activity 2.25-fold (Table S7). In a previous study, H2O2 was proposed to degrade Hb and to release 
the iron ion from Hb, which reacts with H2O2 to form reactive •OH20. We then investigated the involvement of 
ROS in the 7,8-DHF-converting activity of Hb. We measured the 7,8-DHF-converting activity of Hb in the pres-
ence of various scavengers for such reactive species (i.e., H2O2, •OH, O2− and 1O2). In this experiment, the tested 
ROS scavengers increased the activity of Hb (Table S8).
Discussion
In humans, flavonoids have several beneficial effects due to such as their antioxidant, anti-inflammatory, antitu-
mor, and estrogenic activities. Because of these attractive functions, many flavonoids have been searched for and 
characterized in plants.
Figure 5. Substrate specificity of Hb. The reaction was carried out in the modified standard assay mixture; 
various flavonoids were used as substrates in place of 7,8-DHF at a concentration of 0.2 mM. ND, no product 
could be detected. ***The pantetheine conjugate was detected, but the peak intensity was too weak to calculate 
the specific activity. The experiments were carried out three times independently.
Heme-containing protein
Specific activity (μmol/min/μmol heme)
Glutathione Cysteine Pantetheine CoA
Hb (Porcine blood) 101 ± 13 99.1 ± 8.3 81.1 ± 5.4 0.033 ± 0.002
Peroxidase (Horse radish) 76.4 ± 8.6 54.6 ± 4.9 76.8 ± 3.8 N.D.
Catalase (Bovine liver) 9.77 ± 2.5 13.4 ± 1.8 154 ± 15 N.D.
Table 2. Flavonoid-converting activity of heme-containing protein. The experiments were carried out three 
times independently.
www.nature.com/scientificreports/
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In animals, dietary flavonoids are absorbed from the intestine and converted into their conjugated metabolites 
in the epithelial cells by enzymes such as uridine-5′-diphosphoglucuronosyltransferase, phenolsulfotransferase, 
catechol-O-methyltransferase, and glutathione S-transferase. The resultant conjugated metabolites and each of 
the corresponding aglycones are excreted into the digestive tract or flow into the portal vein through specific 
transporter systems. Flavonoids absorbed from the intestine are transferred to and also metabolized in the liver. 
Then, some resulting metabolized flavonoids are transferred from the liver to the bloodstream, the others being 
mixed with bile and returned to the intestinal tract via the enterohepatic circulation21. Studies on the metabolic 
fate of flavonoids are important to understand the bioavailability and function of a flavonoid. However, there are 
flavonoids of which the metabolic pathways have not been clarified such as 7,8-dihydroxyflavone (7,8-DHF).
7,8-DHF exerts a protecting effect on neurons22, improves memory23, antagonizes depression24, and functions 
as a vasorelaxing and hypertensive agent25. Although these beneficial effects have attracted interest, the metabo-
lism of 7.8-DHF has never been investigated.
In this study, we explored novel metabolism of a flavonoid in mammals, using pig liver and 7,8-DHF as 
the enzyme source and substrate, respectively. At last, we successfully identified CoA as another substrate for 
pantetheine-conjugating activity of cell-free extracts toward 7,8-DHF. Surprisingly, we found that Hb, which 
is usually considered as an oxygen transporter, catalyzed this conjugation reaction. We clarified that the novel 
Hb-catalyzed reaction consists of CoA degradation into pantetheine and 3′-phospho-ADP and synthesis of pan-
tetheine conjugated flavonoids, which are novel compounds (Fig. 3).
As found in a previous study, the NH2 group of the Val-1(β), Lys-82(β) and Lys-144(β) of human Hb attacks 
the carbon of the ester bond (-COO-) of the methyl acetyl phosphate to yield acetylated Hb26. This is a type of 
chemical modification of Hb and such covalent chemical modification inhibits the sickling of red blood cells27. 
In another study, enzyme-like activities of Hb were found. For example, hydroxylase-28, hydrolase-29, oxygenase-, 
peroxidase- and catalase activities30,31 have been reported. Among these reactions, only the hydroxylation reac-
tion was analyzed kinetically and it was shown to be a Michaelis-Menten-type reaction. In our study, the hydro-
lytic cleavage of CoA and conjugation of the resulting pantheteine to 7,8-DHF showed typical Michaelis-Menten 
kinetics, and Km for 7.8-DHF was calculated to be 0.4 mM. To the best of our knowledge, conjugating activity 
of Hb toward flavonoids has never been reported. In Hb, the degradation of CoA into pantetheine would be a 
rate-limiting step, because the specific activities of Hb for pantetheine conjugation and that for CoA hydroly-
sis were 1.01 ± 0.11 μmol/min/mg and 0.657 ± 0.105 × 10−3 μmol/min/mg, respectively. In the common deg-
radation pathway for CoA, CoA is first dephosphorylated (Fig. 2, arrow X), and then cleaved (Fig. 2, arrow Y) 
into 4′-phosphopantetheine and the resulting dephosphorylated adenosine moiety by CoA phosphatase and 
dephospho-CoA pyrophosphatase, respectively32. On the contrary, we found that Hb catalyzed the degradation 
of CoA at the cleavage site between the pantetheine moiety and phosphate (Fig. 2, arrow Z). This cleavage site is 
different from those for the CoA-degrading reactions catalyzed by the above enzymes. Moreover, carbon mon-
oxide (CO) did not inhibit this reaction catalyzed by Hb, demonstrating that the hydrolysis of CoA was carried 
out independent of heme. This is the first example that Hb showed the enzymatic activity regardless of the heme.
In general, heme functions as an active site in heme-containing enzymes. Because Hb has a heme in each subunit, 
we assumed that heme is involved in the catalysis of the 7,8-DHF-converting reaction. To examine this speculation, we 
investigated the effects of redox reagents and exogenous ligands on the 7,8-DHF-converting activity of Hb. CO is known 
to bind to the ferrous iron (Fe2+) of Hb with much higher affinity than O2, i.e., about 210-fold higher33. On the other 
hand, potassium cyanide (KCN) specifically binds to the ferric iron (Fe3+). Enzyme assays under these conditions have 
revealed that reduced and dioxygenated (Fe2+-O2) or oxidized (Fe3+) heme was required for the 7,8-DHF-converting 
activity of Hb with CoA as a substrate. In the blood circulatory system, Hb with Fe2+-O2 and Fe3+ accounts for a large 
portion of total Hb. This suggests that Hb could exert flavonoid-converting activity under physiological conditions. In 
previous studies, Hb was found to catalyze hydroxylation and peroxidation of aniline29 and anthracene31, respectively. 
Both reactions are suggested to be catalyzed by heme in Hb. This means the pocket around heme is enough wide for 
a flavonoid (whose size is similar to the above aromatic compounds) to bind. Therefore, the reaction of pantetheine 
conjugation to 7,8-DHF possibly proceeds on the heme-binding site. However, it is not clear that the space around the 
heme of Hb is wide enough for binding of CoA, because CoA is bigger than 7,8-DHF. We assume that the hydrolysis of 
CoA would proceed on a site other than the heme-binding site of Hb. In heme-containing enzymes, reactions in which 
hydrogen peroxide acts as a mediator are also known34. In our study, however, reactive oxygen species (ROS) scavenger 
experiments showed that ROS including hydrogen peroxide are not involved in this reaction.
We here propose a possible reaction mechanism of pantetheine conjugation after CoA hydrolysis by anal-
ogy with the hydroxylation catalyzed by cytochrome P450s. Cytochrome P450s catalyze the hydroxylation of 
substrates after the formation of the key intermediate Compound I (Fe4+•=O). The heme iron of cytochrome 
P450 binds to O2, and then forms Compound I via electron transfer from NAD(P)H to the oxygen atom in the 
P450-catalyzed reaction. We speculate that Hb catalyzes the pantetheine conjugation of a flavonoid via the forma-
tion of the same intermediate Compound I using pantetheine as an electron donor instead of NAD(P)H. A possi-
ble reaction mechanism of the pantetheine conjugation catalyzed by Hb is as follows: (i) the oxygen of oxygenated 
ferrous heme (Fe2+-O2) of Hb is reduced by pantetheine (in the case of ferric heme [Fe3+], it is reduced to ferrous 
[Fe2+] by thiol, and then the resulting Fe2+ binds to O2 before the reduction by pantetheine described above), (ii) 
through protonation of the resulting reduced oxygen (Fe2+-O-O−), the intra-molecular O-O bond is cleaved to 
yield Compound I (Fe4+•=O) with heme, (iii) Compound I abstracts the proton of C-6 of 7,8-DHF, and (iv) the 
resulting electrophilic C-6 is attacked by thiol to form a thiol conjugate. Induction of the 7,8-DHF-converting 
activity (2.25-fold) of Hb by H2O2 (Table S7) would support this hypothesis, because it is proposed that H2O2 
reacts with Hb and forms a compound I-like ferryl derivative (Fe4+=O) with a radical site on a porphyrin or 
protein35. Furthermore, peroxidase and catalase may also catalyze pantetheine conjugation of 7,8-DHF in similar 
mechanisms, as Compound I and mechanisms of its formation involving dioxygen or its derivatives are likely to 
be a shared feature across those heme-proteins36.
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Interestingly, Hb was also able to conjugate flavonoids with glutathione as well as pantetheine (Table 1, 
Table S6). Although glutathione conjugation is an important metabolic reaction, in general, glutathione 
S-transferase is the only known enzyme that catalyzes this reaction37. Expression of glutathione S-transferase is 
induced by various compounds, such as aromatic compounds or isothiocyanates, that are recognized as substrates 
by this enzyme. Flavonoids also induce the expression of glutathione S-transferase38, but flavonoids cannot act 
as substrates for glutathione S-transferase. It is proposed that flavonoids are inhibitors rather than substrates for 
glutathione S-transferase, because flavonoids bind to the cysteine residue near the active site of this enzyme39. 
Although a glutathione conjugate of quercetin has been detected and identified on LC-MS/MS in humans40, 
glutathione S-transferase has not been identified as the responsible enzyme because of this inhibitory effect of 
flavonoids. In the present study, we found that Hb had glutathione-conjugating activity. Taking into account 
the abundance of Hb in the liver, Hb may act as an alternative metabolic enzyme for glutathione conjugation of 
flavonoids after absorption in the small intestine. In other words, Hb could make up for the lack of the ability of 
glutathione S-transferase as to flavonoids.
We also found that Hb can act on other flavonoids as well as 7,8-DHF (Fig. 5, Table S6). The finding that Hb 
can act on these flavonoids (quercetin, catechin and naringenin) shows that a wide range of flavonoids in dietary 
plants are recognized as substrates by Hb. Furthermore, this is the first report showing that isoflavones, whose 
glutathione or cysteine conjugates have never previously been reported, undergo pantetheine conjugation cata-
lyzed by Hb. In general, glutathione conjugation of a variety of polyphenols frequently enhances redox activity, 
and the conjugates exhibit a wide array of cellular activities41. As pantetheine conjugation of flavonoids has never 
been reported before, elucidation of the bioactivity and metabolic fate of the conjugates is expected.
Hb is the most studied protein in human history, in terms of physiological function and molecular structure. 
Although the primary role of Hb in vertebrates is to transport molecular oxygen, our findings are the first to 
show that Hb can act as an enzyme that converts flavonoids into the thiol conjugates using CoA, pantetheine, 
glutathione, or cysteine as a substrate. Human Hb was also found to have 7,8-DHF-converting activity (Table S3). 
We thus suggest that the novel activity is common to Hb of both pigs and humans.
A recent hypothesis42 proposes that an oxygen-transport protein, hemocyanin, is an origin of tyrosinase and 
catechol oxidase which catalyze oxidative reactions and share the distinct metal-containing structure of the active 
site with hemocyanin. However, the fact that hemocyanin also catalyzes tyrosinase- and catechol oxidase-like 
phenol oxidation indicates that the oxygen-transport protein can catalyze the oxidative reaction according to the 
substrate-binding geometry43. Therefore it is not unreasonable that Hb, which is also a metal-containing oxygen 
transport protein, oxidatively added each of the thiol substrates to 7,8-DHF in our study. On the other hand, it is 
very surprising that Hb catalyzes the hydrolysis of CoA into pantetheine and 3′-phospho-ADP independently of 
heme of Hb. This hydrolytic activity is a new function of Hb.
Whether the substrates used in this study are the physiological substrates for Hb or not, our discovery of the 
novel ability of Hb is important. Although the specific activity of the Hb-catalyzed reaction is low, this does not 
rule out the possibility that the enzymatic activity of Hb, which exists abundantly in liver and blood, is physiolog-
ically significant. As physiological importance of thiol conjugates of flavonoids was not investigated, elucidation 
of their effects on human is the next challenge. Our findings pave the way to further studies on this new function, 
in which heme or polypeptide regions in Hb are involved, and new physiological roles are revealed for this ubiq-
uitous protein.
Methods
Matrix-assisted laser desorption ionization time-of-flight mass spectrometry (MALDI-TOF/MS) analysis, 
Quantification of the reaction product, Structural analysis of the reaction product, Quantification of H2O2 pro-
duction in the presence of 7,8-DHF, Effects of various ROS scavengers on the 7,8-DHF-converting activity of Hb.
Please see Supplementary Methods.
Materials. 7,8-Dihdroxyflavone, 7-hydroxyflavone, 4′-hydroxyflavone, flavone, quercetin, naringenin, and 
4-aminoantipyrine were purchased from Tokyo Kasei Kogyo Co., Ltd. (Tokyo, Japan). (+)-Catechin, pantethine, 
superoxide dismutase (from bovine liver), hemoglobin (from humans), and carboxypeptidase B were purchased 
from Sigma (Missouri, USA). 4′,5-Dihydroxyflavone was purchased from Alfa Aesar (Massachusetts, USA). 
CoA and peroxidase (from horseradish) were purchased from Oriental Yeast (Tokyo, Japan). Catalase (from 
bovine liver) was purchased from Wako Pure Chemical Industries, Ltd. (Osaka, Japan). Resource Q, HiPrep 
DEAE FF 16/10, and a low molecular weight standard kit were obtained from GE Healthcare (Buckinghamshire, 
UK). Bio-Scale mini cartridges CHT Type I 40 µm media (5 ml) were obtained from Bio-Rad (California, USA). 
The “Protease inhibitor cocktail for use with mammalian cell and tissue extracts” was purchased from Nacalai 
Tesque (Kyoto, Japan). N-Ethyl-N-(2-hydroxy-3-sulfopropyl)-3,5-dimethoxyaniline was purchased from Dojindo 
(Kumamoto, Japan). All other chemicals used were from commercial sources and of analytical grade. Porcine 
liver and blood were collected from the same individual.
Analysis of the reaction product obtained on incubation with cell-free extracts. Porcine liver 
was homogenized using a POLYTRON PT 10–35 GT (Kinematica, Lucerne, Switzerland), and then the cells 
were disrupted by sonication (Insonator model 201M; Kubota, Tokyo, Japan) in phosphate-buffered saline 
(PBS) containing 1% (vol/vol) of protease inhibitors (as described under “Materials”). Cell debris was removed 
by centrifugation (12,000 g × 20 min). The resulting supernatant was used as a cell-free extract. The reaction 
mixture comprised 50 mM Hepes-NaOH buffer (pH 7.4), 5 mg/ml protein, 1 mM 7,8-DHF (in dimethyl sul-
foxide [DMSO]), and 1 mM cofactor in a total volume of 200 µl. The reaction was started by adding a cell-free 
extract, followed by incubation for 10 h at 37 °C. The reaction product was analyzed by liquid-chromatography 
electrospray-ionization mass spectrometry (LC-ESI-MS) and high-resolution mass spectrometry (HRMS). 
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LC-ESI-MS analysis was performed with a Nexera X2 system (Shimadzu, Kyoto, Japan) equipped with a Cosmosil 
πNAP column 4.6 × 150 mm (Nacalai Tesque). HRMS analysis was performed with a UPLC/Synapt G2 HDMS 
(Waters, Massachusetts, USA) equipped with an ACQUITY UPLC BEH C18 column (Waters).
Purification of the 7,8-DHF-converting enzyme from porcine liver. All purification procedures 
were performed at 0–4 °C. Cell-free extracts were prepared as described above and fractioned with ammonium 
sulfate (40–60% saturation), followed by dialysis against 20 mM Tris-HCl buffer (pH 8.0). Each dialyzed solution 
was applied to a Resource Q column (6 ml) equilibrated with the same buffer. Protein was eluted from the column 
by increasing NaCl linearly from 0 to 1 M in the same buffer. The active fractions were collected and then dialyzed 
against 1 mM potassium phosphate buffer (pH 7.5). The protein solution was applied to a CHT Type I column 
equilibrated with the same buffer. The protein was eluted by increasing the concentration of the potassium phos-
phate buffer linearly from 0 to 500 mM. The active fractions were collected and then dialyzed against 20 mM 
Tris-HCl buffer (pH 8.0). The protein solution was applied to a Resource Q column (6 ml) equilibrated with the 
same buffer. Protein was eluted from the column by increasing NaCl linearly from 0 to 1 M. The active fractions 
were collected and then dialyzed against 10 mM Hepes-NaOH buffer (pH 7.4). The homogeneity of the purified 
protein was confirmed by SDS-PAGE. The relative molecular mass of the enzyme subunit was determined from 
the relative mobility of marker proteins on SDS-PAGE, phosphorylase b (97 kDa), BSA (66 kDa), ovalbumin 
(45 kDa), carbonic anhydrase (30 kDa), soybean trypsin inhibitor (20.1 kDa), and alpha-lactalbumin (14.4 kDa).
Enzyme assays. All of the reactions were performed under linear conditions with an appropriate amount 
of protein and a suitable reaction time, unless otherwise noted. The standard assay mixture comprised 100 mM 
Hepes-NaOH buffer (pH 7.4), 1 mM 7,8-DHF (in DMSO), 2 mM CoA, and an appropriate amount of enzyme in a 
total volume of 200 µl. This standard assay mixture was used for the assaying of 7,8-DHF-converting activity, with 
the exception of investigation of the substrate specificity, for which the concentration of flavonoids was 0.2 mM. 
In these standard assays, the reaction was started by addition of the enzyme and carried out at 37 °C. The reaction 
was stopped by the addition of 200 µl acetonitrile to the reaction mixture, and a supernatant was obtained by 
centrifugation (20,630 × g, 10 min).
One unit of the 7,8-DHF-converting activity was defined as the amount of the enzyme that catalyzed the 
production of 1 µmol pantetheine conjugate per hour under the standard assay conditions. The concentration 
of the pantetheine conjugate was calculated from a standard curve established from the peak area of the purified 
pantetheine conjugate of 7,8-DHF in a mass chromatogram (m/z 529.2 [M-H]−). Specific activity is expressed 
as units per milligram of protein. The protein concentrations were determined with a protein assay kit (Nacalai 
Tesque) using bovine serum albumin as the standard, as in the method of Bradford44.
Flavonoid-converting activity of heme-containing enzymes. Heme contents of heme-containing 
enzymes were analyzed with a pyridine hemochrome method45. An extinction coefficient value for heme B pyri-
dine hemochrome of 34.4 mM−1 cm−1 at 557 nm was used46. Each heme-containing enzyme was added to the 
standard assay mixture. The final concentration of each heme-containing enzyme was 25 µM. After incubation at 
37 °C, reaction mixtures were analyzed by LC/MS.
Substrate specificity. The following flavonoids were examined as to substrate specificity at final con-
centrations of 0.2–1 mM: quercetin, genistein, daidzein, apigenin, naringenin, (+)-catechin, (−)-epicatechin, 
(+)-taxifolin, 7-hydroxyflavone, 4′, 5-dihydroxyflavone, 4′-hydroxyflavone, and flavone. Each of these flavonoids 
was added to standard assay mixture instead of 7,8-DHF. The production of the pantetheine conjugates was 
detected by LC-ESI-MS.
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